European Journal of Clinical Pharmacology

European Journal of Clinical Pharmacology is a peer-reviewed medical journal publishing original research, reviews, and case reports in clinical pharmacology and therapeutics. The journal serves as a venue for clinical investigators, regulatory authorities, and hospital pharmacists to disseminate findings on pharmacokinetics, pharmacodynamics, adverse drug reactions, and therapeutic trials. Authors and readers include clinicians and researchers affiliated with institutions such as Karolinska Institute, University of Oxford, University of Cambridge, Harvard Medical School and University of Toronto.

History

The journal was established in 1968 during a period of expansion in post-war European biomedical publishing associated with publishers like Springer Science+Business Media and contemporaneous titles such as The Lancet, British Medical Journal, and New England Journal of Medicine. Early editorial leadership drew contributors from centers including Karolinska Institute, University of Paris, University of Bologna, and Charité – Universitätsmedizin Berlin while engaging regulatory stakeholders such as European Medicines Agency, Food and Drug Administration, and national agencies in the Ministry of Health (France). Over successive decades the journal published landmark reports connecting clinical pharmacology with multicenter trials led by groups at Mayo Clinic, Cleveland Clinic, Imperial College London, and networks like European Clinical Research Infrastructure Network.

Scope and Content

The journal covers clinical trials, pharmacokinetic and pharmacodynamic studies, therapeutic drug monitoring, drug safety surveillance, and pharmacogenetics with submissions from research groups at Max Planck Society, Wellcome Trust, Medical Research Council, and university hospitals such as Rigshospitalet, Hospital Clínic de Barcelona, and Karolinska University Hospital. Topics frequently intersect with guidelines and position papers from bodies including World Health Organization, Council of Europe, European Commission, and specialty societies like European Society of Clinical Pharmacy, European Society of Cardiology, and European Respiratory Society. Reviews and meta-analyses often reference trials conducted in collaboration with consortia such as Cochrane Collaboration, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and networks funded by Horizon 2020 and European Research Council grants.

Editorial and Publishing Details

Published monthly by Springer Science+Business Media, the journal operates under an editorial board comprising editors and associate editors affiliated with institutions including Karolinska Institute, University College London, ETH Zurich, University of Milan, and Vrije Universiteit Amsterdam. Submission and peer review workflows are aligned with standards promoted by organizations such as Committee on Publication Ethics and indexing expectations of services like Clarivate Analytics. The publisher’s backlist and online platform situate the title alongside other medical journals published by Springer and partnerships with academic societies, philanthropic funders such as Wellcome Trust and Bill & Melinda Gates Foundation, and research infrastructures like PubMed Central and CrossRef.

Abstracting and Indexing

The journal is abstracted and indexed in major databases and citation services used by researchers at institutions such as Harvard University, Yale University, and University of Tokyo, and appears in indexing platforms including PubMed, Scopus, Web of Science, and Embase. Inclusion in these services enhances discoverability for clinical investigators connected with trials at Johns Hopkins Hospital, Karolinska University Hospital, and networked projects like European Clinical Trials Directive-related studies. Indexing supports systematic reviewers working with resources from Cochrane Library, PROSPERO, and national registries such as ClinicalTrials.gov.

Impact and Reception

The journal’s impact factor, cited in evaluation exercises alongside journals like The Lancet, JAMA, and BMJ, reflects its role in clinical pharmacology discourse and guideline development. Articles from the journal have been cited in regulatory assessments by European Medicines Agency and clinical guidelines from specialty societies such as European Society of Cardiology and European Association for the Study of Diabetes. The readership spans clinicians and policy-makers at institutions including NHS England, Agence nationale de sécurité du médicament et des produits de santé, and international organizations such as World Health Organization, while academic influence is evident in citations within publications from research centers like Institut Pasteur, Max Planck Institute for Psychiatry, and CNRS.

Category:Pharmacology journals Category:Monthly journals Category:Springer Science+Business Media academic journals